Fundraising Fox

Cadence Neuroscience

Sammamish, US · Founded 2017 · Delaware corporation · 5 known investors

cadenceneuro.com

Cadence develops a neuromodulation system intended to be a more effective, less invasive treatment for people living with drug-refractory epilepsy. The medical device is designed to be adaptable to individual patient needs and was developed in collaboration with Mayo Clinic.

BiotechDigital HealthHealthtechMedical Devicesin /cadence-neuroscience-inc

Founders & leadership

KL
Kent LeydeExecutive Officer, Director, Promoter
WD
Warren Douglas SheffieldExecutive Officer, Director, Promoter

Investors · 5

Reported raises · per SEC filings

Form D private placements
$26MraisedFeb 2023 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John HarrisDirector
  • Kevin ChuDirector
  • Kent LeydeExecutive Officer, Director
  • Gerry BrunkDirector
  • Warren Douglas SheffieldExecutive Officer
Offering amount
$26M
Amount sold
$26M
First sale
Feb 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$3MraisedSep 2019 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kent LeydeExecutive Officer, Director, Promoter
  • Warren Douglas SheffieldExecutive Officer, Director, Promoter
  • Andrew FirlikDirector
  • John HarrisDirector
Offering amount
$15M
Amount sold
$3M
First sale
Sep 2019
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
Undisclosed amountofferedJul 2017 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kent LeydeExecutive Officer, Director, Promoter
  • Warren Douglas SheffieldExecutive Officer, Director, Promoter
First sale
Jul 2017
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.